State Tobacco Monopoly Administration Releases Typical Cases of E-Cigarette Law Enforcement

Nov.07.2024
State Tobacco Monopoly Administration Releases Typical Cases of E-Cigarette Law Enforcement
The State Tobacco Monopoly Administration has strengthened e-cigarette regulation by releasing three typical cases to intensify the crackdown on illegal activities within the industry.

2Firsts Reprinted and Translated from the State Tobacco Monopoly Administration

 

This year, tobacco monopoly administrative departments at all levels have resolutely implemented the decisions and directives of the Central Committee of the Communist Party and the State Council, strengthening the full-chain regulation of e-cigarettes.

 

They have taken strong action against illegal and non-compliant e-cigarette activities, investigating and addressing administrative cases in accordance with the law, while continuously working to purify the market order and environment for e-cigarettes. To maximize their deterrent effect, the State Tobacco Monopoly Administration has released three typical cases of e-cigarette law enforcement.

 

 

Zhejiang Mirui Sales of Illegally Manufactured E-Cigarette Products

 

 

From January 2024 until the case was discovered, Zhejiang Mirui Electronic Technology Co., Ltd. (e-cigarette brand holder, tobacco monopoly manufacturing license number: 7133020055, hereinafter referred to as Zhejiang Mirui) repeatedly instructed Shenzhen Langyou Biotechnology Co., Ltd. (a vaporizer production company, tobacco monopoly manufacturing license number: 4144030089, hereinafter referred to as Shenzhen Langyou) to add ingredients to domestic e-cigarette products, such as the "MR Miroo - Meteor Disposable E-Cigarette (Wu Ti)," that were not included in the technically reviewed formula.

 

This resulted in discrepancies between the actual products and the information approved through the technical review, constituting the sale of illegally produced e-cigarette products. In accordance with relevant laws and regulations, Zhejiang Mirui was ordered to cease selling the products, confiscate the illegal gains, and pay a fine of 1.0012 million yuan. Shenzhen Langyou has been dealt with in a separate case.

 

 

Shenzhen Bode Sales of Illegally Manufactured E-Cigarette Products, Operating Outside the Permitted Scope of Vaporizer Production

 

 

From January 2024 until the case was discovered, Boulder (Shenzhen) Technologies, Inc. (e-cigarette brand holder, tobacco monopoly manufacturing license number: 7144030063, hereinafter referred to as Shenzhen Boulder) added ingredients to domestic e-cigarette products like the "Bode Boulder - Classic Series - Jade Dragon Snow Mountain" that were not included in the technically reviewed formula. This led to discrepancies between the products and the approved technical review information, constituting the sale of illegally produced e-cigarette products. 

 

Additionally, Shenzhen Boulder did not possess the qualification to produce vaporizers and, from October 2022 to May 2024, it produced and exported vaporizers, thus engaging in business activities outside its permitted scope. In accordance with relevant laws and regulations, Shenzhen Boulder was ordered to stop selling the related e-cigarette products, fined 3.1514 million yuan, publicly destroyed the illegally sold e-cigarette products, suspended production and business activities for two months, and underwent business rectification.

 

 

Shenzhen Mevol Sales of Illegally Manufactured E-Cigarette Products

 

 

From November 2023 to February 2024, Shenzhen Mevol Chuangxin Technology Co. (e-cigarette brand holder, tobacco monopoly manufacturing license number: 7144030126, hereinafter referred to as Shenzhen Mevol) knowingly sold e-cigarette products such as the "Miwo Mevol-Go·Sangyu Muyu," despite discrepancies between the products and those approved through technical review. 

 

This constitutes the sale of illegally manufactured e-cigarette products. In accordance with relevant laws and regulations, Shenzhen Mevol was ordered to stop selling the related e-cigarette products, fined 805,200 yuan, and publicly destroyed the illegally sold products.

 

 

Case Warnings

 

 

In order to prevent the inducement of minors to use e-cigarettes and to safeguard public health and safety, the "E-Cigarette Management Measures" explicitly stipulate that e-cigarette products not approved through technical review must not be marketed or sold. Products available on the market must align with the information of those that have passed the technical review.

 

The companies involved in these cases, motivated by profit, have violated national laws, regulations, and regulatory provisions by introducing ingredients outside the approved technical formulas into domestic e-cigarette products. As a result, these products did not conform to the approved specifications.、

 

Such actions pose a significant risk to public health, particularly the health of minors, disrupt the integrity of the e-cigarette market, and necessitate legal investigation and appropriate penalties. The typical cases published in this instance underscore the steadfast commitment of the tobacco monopoly administrative authorities to enforce e-cigarette regulation in strict accordance with the law.

 

Moving forward, tobacco monopoly administrative departments at all levels will diligently fulfill their responsibilities in e-cigarette regulation, intensify oversight, and actively investigate similar cases. They will further strengthen legal protections against the harmful effects of e-cigarettes on minors, safeguard public health, and expedite the establishment of a robust quality assurance system for e-cigarette products.

 

The responsibility for product quality will be firmly placed on the producers of e-cigarettes, with stringent supervision over the establishment and implementation of internal quality control management systems. Additionally, efforts will be made to enhance legal education and policy dissemination, guiding e-cigarette operators to comply with laws and regulations. In doing so, the regulatory framework governing e-cigarettes will continue to be strengthened, ensuring the ongoing consolidation of legal and regulatory achievements in e-cigarette governance.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Malaysia’s Vape Rules Face Review as Health Minister Dzulkefly Ahmad Addresses Dropped Nicotine Appeal
Malaysia’s Vape Rules Face Review as Health Minister Dzulkefly Ahmad Addresses Dropped Nicotine Appeal
According to Free Malaysia Today on August 26, 2026, Malaysia’s Health Minister Dzulkefly Ahmad said the Health Ministry would explain the government’s decision to withdraw its appeal against a High Court ruling involving the exemption of liquid nicotine used in vape products from the Poisons List. The High Court previously ruled that the exemption decision was irrational. Dzulkefly said withdrawing the appeal did not mean the government would stop regulating vaping, and that future regulatory approaches would continue under existing legal frameworks.
Aug.28
Product | PMI Japan Expands ZYN by IQOS Strength Portfolio With Strong Series, Increasing Lineup to 12 Products
Product | PMI Japan Expands ZYN by IQOS Strength Portfolio With Strong Series, Increasing Lineup to 12 Products
Philip Morris Japan (PMJ) has expanded the ZYN by IQOS oral tobacco pouch portfolio in Japan with four new ZYN Strong products, adding a third intensity level alongside the existing Low and Medium ranges. The Strong series first entered selected duty-free channels in Japan on July 1, 2026, before expanding to IQOS stores, the ZYN Online Store and selected tobacco retailers from August 18. The expansion increases the Japanese ZYN by IQOS lineup from eight to 12 products.
Aug.20
Minnesota Sues Loon as State Enforcement Targets U.S. Vape Brand Operators
Minnesota Sues Loon as State Enforcement Targets U.S. Vape Brand Operators
Minnesota Attorney General Keith Ellison sued Maduro Distributors, Inc., doing business as Loon, on July 15, 2026, alleging that the company illegally manufactured, distributed and sold flavored vapes that appeal to minors.
Jul.16
Ireland’s Vape Tax Raises €22 Million in Nine Months as Government Considers 2027 Budget Changes
Ireland’s Vape Tax Raises €22 Million in Nine Months as Government Considers 2027 Budget Changes
According to Irish media outlets Highland Radio and BreakingNews.ie, the Irish government is considering whether to adjust vape tax policy in the 2027 Budget. The tax has generated about €22 million ($24 million) in revenue during its first nine months. While no increase has been confirmed, the revenue performance could influence future fiscal discussions. Any tax rise could increase product costs and potentially affect retail prices.
Aug.12
Australia’s Daily Smoking Rate Falls to Record Low of 5.8% as Nicotine Use Patterns Shift
Australia’s Daily Smoking Rate Falls to Record Low of 5.8% as Nicotine Use Patterns Shift
According to the Australian Institute of Health and Welfare’s National Drug Strategy Household Survey, daily smoking among Australians aged 18 and over fell to a record low of 5.8% in 2025. Health Minister Mark Butler said Australia now has around 500,000 fewer daily smokers than three years ago and credited the government’s vaping reforms as part of broader progress. Among people aged 14 and over, daily smoking declined from 8.3% in 2022-23 to 5.6% in 2025. Daily vaping rates stabilised at 3.6%, while the government also moved to further restrict access to nicotine pouches through unapproved therapeutic import pathways.
Jul.21
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13